Events Search and Views Navigation
May 2021
Large scale functional genomics strategies for enabling cancer precision medicine by identification of new drug targets and risk alleles
Find out moreJune 2021
Convergence of Public Health and Precision Oncology into Precision Public Health
Find out moreAugust 2021
Optimized 5 hydroxy-methyl seq of ctDNA as a biomarker of response in metastatic prostate cancer
Find out moreOctober 2021
“The COLUMN initiative:- Using comprehensive whole-genome & transcriptome analyses to improve diagnosis and therapeutic selection for cancers of low survival and unmet need”. The Cancer of [...]
Find out moreDecember 2021
General and Endocrine Surgeon, The Alfred, Monash Health, Epworth Healthcare “The evolving role of molecular markers in the management of patients with thyroid cancer” Molecular [...]
Find out moreFebruary 2022
Head, Centre for Cancer Research, Hudson Institute of Medical Research “Functional Precision Oncology: Moving Beyond Genomic Sequencing” Professor Firestein will discuss how functional interrogation of [...]
Find out moreApril 2022
Dr Ameratunga will discuss how novel computational approaches could be utilised to expand the array of therapies available to patients with poor prognosis and aggressive cancers.
Find out moreMay 2022
NHMRC Leadership Fellow & Head Cancer Immunotherapy Laboratory, Monash Biomedicine Discovery Institute "Targeting Natural Killer cells in cancer immunotherapy" Prof Huntington will present recent clinical [...]
Find out moreJuly 2022
Comprehensive Genomic Profiling plus the detection of Homologous Recombination Deficiency (HRD) with a gold-standard assay
Find out more
Towards a new era in granulosa cell tumour research: patient driven outcomes, genomics, diagnostics and therapeutics
Find out more